Hepatitis C is a potentially deadly liver disease that affects an estimated 3.5 million people in the United States and up to 150 million worldwide. In fact, it kills more Americans than all other infectious diseases together! But in just the past few years, advances in treatment have been nothing short of astounding. A condition once treated with medication that caused serious side effects and delivered a low cure rate is now curable almost all of the t...
The hepatitis C outbreak at two Northern Utah hospitals, attributed to a nurse accused of diverting drugs and infecting at least 7 patients, has spurred the state to increase monitoring of health care professionals. The Utah Department of Health has begun working more closely with licensing authorities “to understand when a provider is potentially exposing patients to blood-borne pathogens due to risky behaviors,” said Dr. Angela Dunn, deputy state epidem
The complications include liver cancer, failure, transplantation or death. Consistent medical monitoring is recommended. Individuals who are treated for hepatitis C virus (HCV) when they have advanced fibrosis or cirrhosis remain at high risk of liver disease progression even after being cured of the virus. Consequently, researchers recommend routine monitoring for this group. Publishing their findings in the Journal of Hepatology, researchers conducte
For a long time, patients with intermediate-stage liver cancer, where the tumour is too large to be removed with surgery, had no clear data on which treatment worked best. One type of treatment directs tiny radioactive spheres to the tumour, while the other is an oral medication - sorafenib - that must be taken as long as the body can bear the side effects. But after seven years of research, a team from Singapore led by National Cancer Centre Singapore
It's time to pay more attention to liver cancer. Even as breast-cancer, lung-cancer and other cancer fatalities continue to drop, liver cancer is now the fastest-rising cause of U.S. cancer deaths, a recent study shows. Since the mid-1980s, death rates from liver cancer have doubled. An estimated 41,000 new cases and 29,000 liver-cancer deaths are expected in 2017. Only 1 in 5 patients survive after being diagnosed with liver cancer, the recent study note
Friday, July 14, 2017 News Recap Local New measures boost addiction treatment access in Victoria New efforts to expand treatment for opioid users in Victoria are putting addiction specialists in hospital emergency departments and supporting family doctors who provide opioid substitution therapy for patients. The initiatives by Island Health and the Victoria Divisions of Family Practice are intended to dovetail with the work of the South Island Ra...
New efforts to expand treatment for opioid users in Victoria are putting addiction specialists in hospital emergency departments and supporting family doctors who provide opioid substitution therapy for patients. The initiatives by Island Health and the Victoria Divisions of Family Practice are intended to dovetail with the work of the South Island Rapid Access Addiction Clinic that opened in the city early this year. The clinic offers streamlined acce
Norwegian hepatitis C patients are waiting longer than they should for medical treatment due in part to a monopoly on its supply, according to a report. Between 15,000 and 20,000 Norwegians live with the chronic condition, which is treated with a 12-week course of medicine. The cost of a 12-week course of the Epclusa medicine in Norway is 540,000 kroner (57,000 euros), according to the Klassekampen newspaper. American pharmaceutical company Gilead S
BRUSSELS, July 11(Xinhua) -- The European Food Safety Authority (EFSA) said on Tuesday that consumption of raw or undercooked pork meat and liver is the most common cause of hepatitis E infection in the European Union (EU). EFSA said in its press release that domestic pigs are the main carriers of hepatitis E in the EU. Though wild boars can also carry the virus, meat from these animals is less commonly consumed. Therefore, experts from EFSA's Panel on
In the Comox Valley a support group provides a safe space for people to get up-to-date information about the disease and treatment options. It is a place where people can go with their questions and concerns and get support from others who have had similar experiences. The group is sponsored by Positive Wellness North Island – North Island Liver Services. “In a small town, knowing where to get confidential information can be hard,” says group facilitat